Changes of NOS Activity and NO Content in Rectal Cancer Tissues
DOI:
https://doi.org/10.46966/msjar.v7i3.424Keywords:
Rectal cancer, NOS activity, NO contentAbstract
Nitric Oxide (NO) plays important role in many pathological processes (inflammation, infection, cell death, neoplastic disease, cirrhosis, diabetes, intestinal disease) and normal physiological processes (blood pressure regulation, neurotransmission, wound healing, host defense mechanisms). we aimed to investigate the relationship between changes in NOS activity and changes in NO content in cancer tissues according to the histopathological classification of rectal cancer. The study population included 102 rectal tissue from rectal cancer patients over the past three years and 33 rectal autopsy specimens from those who had not experienced any inflammatory or neoplastic disease in the past. The activity of NOS in rectal tissue was determined by the Griess’ method and the citrulline assay for NO production, and the NO content was determined by the Griess’ method. Histopathological examination of histotype, depth and differentiation was performed on microscopic images, and the histopathological parameters of rectal cancer were compared with the changes in NOS activity and NO content in the cancer tissues and t-tests were performed. The changes in NOS activity and NO content in rectal cancer tissues are as follows. In rectal cancer, NOS activity and NO content in cancer tissues were significantly higher than those in healthy controls (0.076±0.002μmol/min and 5.84±0.17μmol/g, significantly) with 0.16±0.01μmol/min and 15.63±0.64μmol/g, significantly. In the histopathological classifications (macroscopic pattern, histotype, depth, and differentiation) in rectal cancer, NOS activity and NO content decreased according to the classification.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Hyon Chol Jo, Song Guk Han, To Myong Kim, Hak Song

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















